Tci Wealth Advisors, Inc. Novavax Inc Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$69.73 - $142.9 $18,269 - $37,439	-262 Reduced 90.66%	27 $2,000
Q4 2021 Jan 24, 2022	BUY	$134.56 - $217.97 $20,856 - $33,785	155 Added 115.67%	289 $41,000
Q3 2021 Oct 29, 2021	BUY	$177.8 - $270.58 $11,734 - $17,858	66 Added 97.06%	134 $28,000
Q2 2021 Aug 02, 2021	BUY	$121.0 - $257.67 $1,210 - $2,576	10 Added 17.24%	68 $14,000
Q1 2021 Apr 29, 2021	BUY	$112.98 - $319.93 $6,552 - $18,555	58 New	58 $11,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.